ReviewNAM perspectives2023
Primary, Secondary, and Tertiary Prevention of Substance Use Disorders through Socioecological Strategies.
Review in NAM perspectives, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Leveraging Artificial Intelligence for Substance Use Prevention Among Adolescents: A Systematic Review of Emerging Evidence.Inquiry : a journal of medical care organization, provision and financingPooled it
- Take-home naloxone (THN) ownership among a community-based cohort of sex workers who use drugs in metro vancouver: longitudinal trends and structural determinants (2017-2024).Harm reduction journal · 2026Article
- Connecticut's substance use primary prevention resource assessment and interactive map initiative.Public health in practice (Oxford, England) · 2026Article
- Rethinking Gaming Disorder Prevention: A Socio-Ecological Model Based on Practitioner Insights.International journal of environmental research and public health · 2026Article
- A two-factor structure for cannabis use disorder identification test and its associations with demographic factors and cannabis use motives.Advances in drug and alcohol research · 2026Article
- Optimizing the right time to start sickle cell therapies.Hematology. American Society of Hematology. Education Program · 2025Review
- The multidimensional social ecological needs and service utilization patterns of youth using non-medical prescription opioids: an observational study of routinely collected data in a provincial integrated youth services initiative.Substance abuse treatment, prevention, and policy · 2025Observational
- Mapping the Landscape: A Scoping Review of Evaluated Substance Use Harm Reduction Programs for Youth.Journal of drug education · 2025Article
- Community-administered naloxone for overdose reversal: The role of sex worker-led programming and occupational violence in a community-based cohort (2018-2024).The International journal on drug policy · 2025Article
- Primal Prevention of Drug Abuse: An Emerging but Unrecognized Public Health Issue.Addiction & health · 2025Article
- Harm reduction techniques among cisgender gay, bisexual, and queer men using anabolic androgenic steroids: a qualitative study.Harm reduction journal · 2024Article
- Descriptive analysis of recommendations made by county-level overdose fatality review teams in indiana to combat the opioid epidemic.Drug and alcohol dependence · 2024Article
- Sleep Health among Community-Recruited Opioid-Using People Who Inject Drugs in Los Angeles, CA and Denver, CO.Journal of urban health : bulletin of the New York Academy of Medicine · 2024Article
- Vulnerable Populations and Substance Use Prevention Service Delivery for the Mental Health Professional.Focus (American Psychiatric Publishing) · 2024Review
- Evaluating remyelination compounds for new applications in opioid use disorder management.Journal of addictive diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.